Literature DB >> 8217796

The presence of messenger RNA for HLA class I in human platelets and its capability for protein biosynthesis.

S Santoso1, R Kalb, V Kiefel, C Mueller-Eckhardt.   

Abstract

In order to determine whether platelets contain specific messenger RNA encoding for HLA class I molecules, polymerase chain reaction (PCR) was performed with RNA from different platelet donors. Two amplified 300 bp and 279 bp cDNA fragments were obtained which encompassed sequences from 321 to 620 and from 795 to 1073. The 300 bp fragment encodes exon 2 and exon 3, the 279 bp encodes a portion of exon 4, exon 5, exon 6 and a portion of exon 7. A 300 bp nested PCR product from one donor, that encoded for the highly polymorphic region alpha 2, was cloned and sequenced. The resulting nucleotide sequences fitted to the expected sequence for HLA B*3801 of this donor. Sequence analysis of the 279 bp PCR product demonstrated the presence of exon 5 encoding for the 117 bp transmembrane domain. In addition, de novo protein biosynthesis was studied by radioimmunoprecipitation of HLA class I molecules from 35S-methionine metabolically labelled platelet lysates with a monoclonal antibody (mab) w6/32 specific for a monomorphic epitope on the heavy chain of HLA class I antigens. Analysis of the immunoprecipitates on SDS polyacrylamide gel electrophoresis showed a specific band with apparent molecular weight (M(r)) of 44 kD corresponding to integral membrane HLA protein. On the basis of these results, we conclude that platelets contain specific messenger RNA encoding for HLA class I molecules and have the capability to synthesize the integral HLA membrane protein.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8217796     DOI: 10.1111/j.1365-2141.1993.tb03100.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  8 in total

Review 1.  Platelets: versatile effector cells in hemostasis, inflammation, and the immune continuum.

Authors:  Adriana Vieira-de-Abreu; Robert A Campbell; Andrew S Weyrich; Guy A Zimmerman
Journal:  Semin Immunopathol       Date:  2011-08-06       Impact factor: 9.623

2.  Identification of serotonin transporter mRNA in rat platelets.

Authors:  D Hranilović; K P Lesch; D Ugarković; L Cicin-Sain; B Jernej
Journal:  J Neural Transm (Vienna)       Date:  1996       Impact factor: 3.575

Review 3.  Platelets in Pulmonary Immune Responses and Inflammatory Lung Diseases.

Authors:  Elizabeth A Middleton; Andrew S Weyrich; Guy A Zimmerman
Journal:  Physiol Rev       Date:  2016-08-03       Impact factor: 37.312

4.  HLAMatchmaker-driven analysis of responses to HLA-typed platelet transfusions in alloimmunized thrombocytopenic patients.

Authors:  Ashok Nambiar; Rene J Duquesnoy; Sharon Adams; Yingdong Zhao; Jaime Oblitas; Susan Leitman; David Stroncek; Francesco Marincola
Journal:  Blood       Date:  2005-11-03       Impact factor: 22.113

5.  Current Status of and Global Trends in Platelet Transfusion Refractoriness From 2004 to 2021: A Bibliometric Analysis.

Authors:  Ying Liu; Yufan Zhang; Dawei Chen; Yongshui Fu
Journal:  Front Med (Lausanne)       Date:  2022-05-06

Review 6.  Protein synthesis by platelets: historical and new perspectives.

Authors:  A S Weyrich; H Schwertz; L W Kraiss; G A Zimmerman
Journal:  J Thromb Haemost       Date:  2008-10-29       Impact factor: 5.824

Review 7.  Tip of the iceberg: roles of circRNAs in hematological malignancies.

Authors:  Shan-Shan Guo; Bi-Xia Li; Duo-Bing Zou; Shu-Jun Yang; Li-Xia Sheng; Gui-Fang Ouyang; Qi-Tian Mu; He Huang
Journal:  Am J Cancer Res       Date:  2020-02-01       Impact factor: 6.166

8.  Selective release of circRNAs in platelet-derived extracellular vesicles.

Authors:  Christian Preußer; Lee-Hsueh Hung; Tim Schneider; Silke Schreiner; Martin Hardt; Anna Moebus; Sentot Santoso; Albrecht Bindereif
Journal:  J Extracell Vesicles       Date:  2018-01-15
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.